Detalhe da pesquisa
1.
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates.
J Infect Dis
; 201(5): 720-9, 2010 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-20132004
2.
Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
PLoS One
; 9(3): e90378, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24609066
3.
Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.
Clin Vaccine Immunol
; 20(3): 397-408, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23345581
4.
A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4ß7-binding V2 loop of HIV gp120 in healthy volunteers.
Clin Vaccine Immunol
; 19(9): 1557-9, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22837097
5.
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
PLoS One
; 7(8): e41936, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22870265
6.
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials.
J Immunol Methods
; 370(1-2): 43-54, 2011 Jul 29.
Artigo
Inglês
| MEDLINE | ID: mdl-21669205
7.
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers.
PLoS One
; 6(5): e19252, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21603651
8.
Equivalence of ELISpot assays demonstrated between major HIV network laboratories.
PLoS One
; 5(12): e14330, 2010 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-21179404
9.
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.
PLoS One
; 5(1): e8617, 2010 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-20111582
10.
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.
PLoS One
; 5(1): e8816, 2010 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-20111599
11.
Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
Clin Vaccine Immunol
; 16(2): 147-55, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19091991
12.
Genital human papillomavirus genotypes in northwestern Tanzania.
J Clin Microbiol
; 41(9): 4451-3, 2003 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12958291